Arcataur Capital Management’s Pfizer PFE Stock Holding History

Arcataur Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Buy	8,497 +115	+1%	+$3.01K	0.05%	101
2026 Q1	$235K	Sell	8,382 -40	-0.5%	-$1.06K	0.07%	100
2025 Q4	$210K	Buy	8,422 +110	+1%	+$2.77K	0.06%	102
2025 Q3	$212K	Buy	+8,312	New	+$205K	0.06%	100
2025 Q1	–	Sell	-7,926	Closed	-$210K	–	100
2024 Q4	$210K	Sell	7,926 -105	-1%	-$2.85K	0.07%	95
2024 Q3	$232K	Sell	8,031 -10	-0.1%	-$292	0.08%	94
2024 Q2	$225K	Sell	8,041 -30	-0.4%	-$826	0.08%	95
2024 Q1	$224K	Hold	8,071	–	–	0.08%	94
2023 Q4	$232K	Buy	8,071 +200	+3%	+$6.05K	0.09%	91
2023 Q3	$261K	Hold	7,871	–	–	0.11%	81
2023 Q2	$289K	Buy	+7,871	New	+$306K	0.12%	81

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Arcataur Capital Management's PFE Position: Q2 2026 in Review

Arcataur Capital Management increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $3.01K and bringing the position to 8,497 shares worth $205K. The position accounts for 0.05% of the portfolio, ranked #101.

Arcataur Capital Management first reported a position in PFE in Q2 2023 and has held it in 11 quarters since. The position peaked at $289K in Q2 2023. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Arcataur Capital Management held 8,497 shares of Pfizer worth $205K as of Q2 2026.
Arcataur Capital Management bought 115 Pfizer shares in Q2 2026, an estimated $3.01K.
Pfizer made up 0.05% of Arcataur Capital Management's portfolio in Q2 2026, its #101 holding.
Arcataur Capital Management first reported a position in Pfizer in Q2 2023 and has held it in 11 quarters since.
Arcataur Capital Management's Pfizer position peaked at $289K in Q2 2023.
2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.